Does Silk Road Medical (NASDAQ:SILK) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Silk Road Medical | 10-Q: Quarterly report
Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Earnings Call Transcript
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Price Target Raised to $21.00/Share From $19.00 by JP Morgan
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Silk Road Medical Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Neutral on Silk Road Medical, Raises Price Target to $20
Piper Sandler analyst Adam Maeder maintains Silk Road Medical (NASDAQ:SILK) with a Neutral and raises the price target from $18 to $20.
Silk Road Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 2.88% Piper Sandler $18 → $20 Maintains Neutral 03/07/2024 23.46% Argus Research → $24 Upgrades
Oppenheimer Reaffirms Their Buy Rating on Silk Road Medical (SILK)
Silk Road Medical Inc (SILK) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...
Silk Road Medical Inc (SILK) Q1 2024 Earnings: Revenue Surpasses Expectations, Losses Narrow
Silk Road Medical Sees FY24 Revenue $194M-$198M Vs $195.923M Est.
Silk Road Medical Sees FY24 Revenue $194M-$198M Vs $195.923M Est.
Silk Road Medical Q1 2024 GAAP EPS $(0.36) Beats $(0.40) Estimate, Sales $48.484M Beat $44.676M Estimate
Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 10 percent. This is a 16.28 percent increase over losses of $(0.4
Silk Road Medical 1Q Rev $48.5M >SILK
Silk Road Medical 1Q Rev $48.5M >SILK
Press Release: Silk Road Medical Reports First Quarter 2024 Financial Results
Silk Road Medical Reports First Quarter 2024 Financial Results SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of
Lake Street Keeps Their Buy Rating on Silk Road Medical (SILK)
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (NASDAQ:SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in
All You Need to Know About Silk Road Medical (SILK) Rating Upgrade to Buy
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
SUNNYVALE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (NASDAQ:SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results
Silk Road Medical (NASDAQ:SILK Shareholders Incur Further Losses as Stock Declines 7.5% This Week, Taking Three-year Losses to 66%
It is a pleasure to report that the Silk Road Medical, Inc (NASDAQ:SILK) is up 49% in the last quarter. Meanwhile over the last three years the stock has dropped hard. Tragically, the share price
Analysts Offer Insights on Healthcare Companies: Silk Road Medical (SILK) and Viemed Healthcare (VMD)
No Data